Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | GALR3 |
| Upstream (Parents) |
|---|
| (<<) CDH22 → GALR3 |
| (<<) PRSS36 → GALR3 |
| (<<) SLC34A3 → GALR3 |
| (<<) UTS2R → GALR3 |
| Downstream (Children) |
|---|
| GALR3 → ACTC1 (>>) |
| GALR3 → ATP10B (>>) |
| GALR3 → CAV3 (>>) |
| GALR3 → CDH24 (>>) |
| GALR3 → DDIT3 (>>) |
| GALR3 → E2F4 (>>) |
| GALR3 → FGF5 (>>) |
| GALR3 → GNRH2 (>>) |
| GALR3 → GPR78 (>>) |
| GALR3 → GSK3A (>>) |
| GALR3 → HDAC10 (>>) |
| GALR3 → HDAC11 (>>) |
| GALR3 → IL23A (>>) |
| GALR3 → IL27 (>>) |
| GALR3 → KLK12 (>>) |
| GALR3 → KRTAP1-3 (>>) |
| GALR3 → LCE3D (>>) |
| GALR3 → MAP2K5 (>>) |
| GALR3 → MYL3 (>>) |
| GALR3 → PLA2G4D (>>) |
| GALR3 → PLA2G6 (>>) |
| GALR3 → SEMA5B (>>) |
| GALR3 → SPRR2G (>>) |
| GALR3 → SYNGR4 (>>) |
| GALR3 → TAF9 (>>) |
| GALR3 → WNT7A (>>) |
| GALR3 → ZNF224 (>>) |
